“Preliminary Prospectus of Qomel Company”
Watheeq Capital announces the Offering of Qomel Company (Qomel) and the listing of its shares on the Parallel Market (“NOMU”)
The Capital Market Authority Announces the Approval on the Registration and Offering shares of Qomel Company in the Parallel Market
The Capital Market Authority Announces the Approval on the Registration and Offering shares of Qomel Company in the Parallel Market
13 / 12 / 2023
The Capital Market Authority “CMA” Board has issued its resolution dated on 29/05/1445H corresponding to 13/12/2023G approving of Qomel Company’s “the Company” application for the registration and offering of (500,000) shares representing (14.29%) of the Company’s share capital in the Parallel Market. The offer will be confined to Qualified Investors stipulated in the Glossary of Defined Terms Used in the Regulations and Rules of the Capital Market Authority. The prospectus will be published within sufficient time prior to the start of the offering.
Prospective Qualified Investors should conduct their own due diligence on the information disclosed in the prospectus. If the prospectus proves difficult to understand, it is recommended to consult with an authorized financial advisor prior to making any investment decision.
The CMA’s approval on the application should never be considered as a recommendation to invest in the offering or shares of the company. The CMA’s approval on the application merely means that the legal requirements as per the Capital Market Law and its Implementing Regulations have been met
The CMA’s approval on the application shall be valid for (6) months from the CMA Board resolution date. The approval shall be deemed cancelled if the offering and listing of the Company’s shares are not completed within this period.
Nerve pain and spasticity medications
Antispasmodic medications are often used to help control the type of pain caused by damaged nerves.
Anticonvulsant drugs are primarily used to treat people with epilepsy. But the nerve-sedating properties of some of these medications can help soothe the feeling of heat, tingling, or sharp pain caused by nerve damage.
What causes pain?
Nerves can be damaged for many reasons, including injury, surgery, illness, or exposure to toxins. Damaged nerves activate improperly and send useless pain signals. This type of pain can be debilitating and difficult to control.
Nerve damage (neuropathy) may be caused by many different conditions, including:
- Diabetes: High blood sugar levels, which is common in people with diabetes, can damage nerves throughout your body. The first sign is generally numbness and pain in the hands and feet (diabetic neuropathy).
- Shingster: Anyone who has previously had chickenpox is at risk of developing shingles, a blistered rash that causes pain or itching. A condition called “postherpetic neuralgia” occurs if the pain of shingles persists after the rash disappears.
- Chemotherapy. Some chemotherapy drugs can damage nerves, causing pain and numbness, generally starting in the tips of the toes and hands (neuropathy).
- Herniated disc. Nerve damage may occur if a herniated disc in the spine puts too much pressure on a nerve that runs through the vertebrae.